Yuflyma® (Adalimumab), Patient Experience After Switching

Clinical trial NCT05427942 · UNKNOWN

Trial details

NCT number: NCT05427942
Sponsor: Celltrion HealthCare France
Status: UNKNOWN
Study type: OBSERVATIONAL

Rheumatoid Arthritis Ankylosing Spondylarthritis Axial Spondyloarthritis Without Radiographic Evidence of Ankylosing Spondylitis Psoriatic Arthritis Crohn Disease Ulcerative Colitis

Start date: 2022-06-03
Primary completion: 2022-12-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.